iNKT Cells Induce FGF21 for Thermogenesis and Are Required for Maximal Weight Loss in GLP1 Therapy.

[1]  R. Gimeno,et al.  Discrete Aspects of FGF21 In Vivo Pharmacology Do Not Require UCP1. , 2015, Cell reports.

[2]  W. D. van Marken Lichtenbelt,et al.  Serum FGF21 levels are associated with brown adipose tissue activity in humans , 2015, Scientific Reports.

[3]  R. Locksley,et al.  Activated Type 2 Innate Lymphoid Cells Regulate Beige Fat Biogenesis , 2015, Cell.

[4]  Jonathan R. Brestoff,et al.  Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity , 2014, Nature.

[5]  G. Besra,et al.  Regulatory iNKT cells lack expression of the transcription factor PLZF and control the homeostasis of Treg cells and macrophages in adipose tissue , 2014, Nature Immunology.

[6]  R. Palmiter,et al.  Eosinophils and Type 2 Cytokine Signaling in Macrophages Orchestrate Development of Functional Beige Fat , 2014, Cell.

[7]  N. Satoh,et al.  Liraglutide Suppresses Obesity and Hyperglycemia Associated with Increases in Hepatic Fibroblast Growth Factor 21 Production in KKAy Mice , 2014, BioMed research international.

[8]  L. Lynch,et al.  Glucagon-like peptide 1 analogue therapy directly modulates innate immune-mediated inflammation in individuals with type 2 diabetes mellitus , 2014, Diabetologia.

[9]  A. Adams,et al.  Inventing new medicines: The FGF21 story☆ , 2013, Molecular metabolism.

[10]  R. Locksley,et al.  Cutting Edge: IL-25 Elicits Innate Lymphoid Type 2 and Type II NKT Cells That Regulate Obesity in Mice , 2013, The Journal of Immunology.

[11]  B. Sloth,et al.  Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults , 2013, International Journal of Obesity.

[12]  H. Fu,et al.  The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes. , 2013, Cell metabolism.

[13]  P. Scherer,et al.  An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice. , 2013, Cell metabolism.

[14]  R. Locksley,et al.  Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages , 2013, The Journal of experimental medicine.

[15]  R. Seong,et al.  A Novel Function of Adipocytes in Lipid Antigen Presentation to iNKT Cells , 2012, Molecular and Cellular Biology.

[16]  Gangyi Yang,et al.  Liraglutide Increases FGF-21 Activity and Insulin Sensitivity in High Fat Diet and Adiponectin Knockdown Induced Insulin Resistance , 2012, PloS one.

[17]  D. Drucker,et al.  Direct Control of Brown Adipose Tissue Thermogenesis by Central Nervous System Glucagon-Like Peptide-1 Receptor Signaling , 2012, Diabetes.

[18]  S. Balk,et al.  Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production. , 2012, Immunity.

[19]  G. Besra,et al.  Natural killer T cells in adipose tissue prevent insulin resistance. , 2012, The Journal of clinical investigation.

[20]  Liu Yang,et al.  Short Term High Fat Diet Challenge Promotes Alternative Macrophage Polarization in Adipose Tissue via Natural Killer T Cells and Interleukin-4* , 2012, The Journal of Biological Chemistry.

[21]  B. Spiegelman,et al.  FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis. , 2012, Genes & development.

[22]  R. Locksley,et al.  Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis , 2011, Nature.

[23]  S. Gortmaker,et al.  Health and economic burden of the projected obesity trends in the USA and the UK , 2011, The Lancet.

[24]  D. Doherty,et al.  Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasis , 2011, Diabetologia.

[25]  K. Siminovitch,et al.  Glucagon-like peptide-1 receptor signalling selectively regulates murine lymphocyte proliferation and maintenance of peripheral regulatory T cells , 2010, Diabetologia.

[26]  S. Enerbäck.  The origins of brown adipose tissue. , 2009, The New England journal of medicine.

[27]  J. Flier,et al.  Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis. , 2009, Endocrinology.

[28]  D. Doherty,et al.  Invariant NKT cells and CD1d+ cells amass in human omentum and are depleted in patients with cancer and obesity , 2009, European journal of immunology.

[29]  T. Elhadd,et al.  Incretin based therapies for type 2 diabetes mellitus. , 2008, Journal of the Indian Medical Association.

[30]  D. Drucker,et al.  Biology of incretins: GLP-1 and GIP. , 2007, Gastroenterology.

[31]  J. Gromada,et al.  FGF-21 as a novel metabolic regulator. , 2005, The Journal of clinical investigation.

[32]  A. Astrup,et al.  The effect of liraglutide, a long-acting glucagon-like peptide 1 derivative, on glycemic control, body composition, and 24-h energy expenditure in patients with type 2 diabetes. , 2004, Diabetes care.

[33]  Michael B Brenner,et al.  CD1: antigen presentation and T cell function. , 2004, Annual review of immunology.

[34]  Hitoshi Yamashita,et al.  Mice lacking mitochondrial uncoupling protein are cold-sensitive but not obese , 1997, nature.

[35]  S. Bloom,et al.  A role for central glucagon‐like peptide‐1 in temperature regulation , 1996, Neuroreport.

[36]  D. Smith,et al.  A role for glucagon-like peptide-1 in the central regulation of feeding , 1996, Nature.

[37]  J. Himms-Hagen,et al.  Effect of CL-316,243, a thermogenic beta 3-agonist, on energy balance and brown and white adipose tissues in rats. , 1994, The American journal of physiology.

[38]  L. Pénicaud,et al.  Occurrence of brown adipocytes in rat white adipose tissue: molecular and morphological characterization. , 1992, Journal of cell science.